{"id":3421,"date":"2025-02-27T23:08:56","date_gmt":"2025-02-27T22:08:56","guid":{"rendered":"https:\/\/www.curavac.com\/?page_id=3421"},"modified":"2025-02-27T23:08:56","modified_gmt":"2025-02-27T22:08:56","slug":"empresa-3","status":"publish","type":"page","link":"https:\/\/www.curavac.com\/es\/empresa-3","title":{"rendered":"Empresa"},"content":{"rendered":"\n<p><strong>CuraVac<\/strong> es una empresa biotecnol\u00f3gica en fase cl\u00ednica que desarrolla Vacunas Terap\u00e9uticas e Inmunoterapias Activas Dirigidas para <a href=\"hts:\/\/www.curavac.com\/autoimmune-diseases\/\">enfermedades autoinmunes.<\/a> Con el uso de una nueva t\u00e9cnica revolucionaria basada en p\u00e9ptidos complementarios, pretendemos inducir inmunidad a largo plazo contra enfermedades autoinmunes como la esclerosis m\u00faltiple (EM), <a href=\"hts:\/\/www.curavac.com\/myasthenia\/\">la miastenia grave (MG)<\/a>, la diabetes de tipo 1, la enfermedad de Graves, el lupus eritematoso sist\u00e9mico (LES) y la enfermedad de Hashimoto. <\/p>\n\n<p>La principal vacuna terap\u00e9utica candidata de CuraVac para la miastenia gravis, <strong>CV-MG<\/strong>, ya ha completado la fase 1B del estudio cl\u00ednico con un excelente perfil de seguridad.<\/p>\n\n<p><strong>Actualmente estamos preparando un ensayo cl\u00ednico de demostraci\u00f3n de eficacia de fase 2.<\/strong><\/p>\n\n<p>El CV-MG de CuraVac es un avance potencial en los tratamientos de la MG y una posible revoluci\u00f3n terap\u00e9utica para todas las enfermedades autoinmunes, <strong>siendo el primero en aportar posiblemente una mejora duradera y una posible cura a los pacientes.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CuraVac es una empresa biotecnol\u00f3gica en fase cl\u00ednica que desarrolla Vacunas Terap\u00e9uticas e Inmunoterapias Activas Dirigidas para enfermedades autoinmunes. Con el uso de una nueva t\u00e9cnica revolucionaria basada en p\u00e9ptidos complementarios, pretendemos inducir inmunidad a largo plazo contra enfermedades autoinmunes como la esclerosis m\u00faltiple (EM), la miastenia grave (MG), la diabetes de tipo 1, la &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.curavac.com\/es\/empresa-3\"> <span class=\"screen-reader-text\">Empresa<\/span> Leer m\u00e1s &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"class_list":["post-3421","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Empresa - CuraVac<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curavac.com\/company-2\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Empresa - CuraVac\" \/>\n<meta property=\"og:description\" content=\"CuraVac es una empresa biotecnol\u00f3gica en fase cl\u00ednica que desarrolla Vacunas Terap\u00e9uticas e Inmunoterapias Activas Dirigidas para enfermedades autoinmunes. Con el uso de una nueva t\u00e9cnica revolucionaria basada en p\u00e9ptidos complementarios, pretendemos inducir inmunidad a largo plazo contra enfermedades autoinmunes como la esclerosis m\u00faltiple (EM), la miastenia grave (MG), la diabetes de tipo 1, la &hellip; Empresa Leer m\u00e1s &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curavac.com\/company-2\" \/>\n<meta property=\"og:site_name\" content=\"CuraVac\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.curavac.com\/company-2\",\"url\":\"https:\/\/www.curavac.com\/company-2\",\"name\":\"Empresa - CuraVac\",\"isPartOf\":{\"@id\":\"https:\/\/www.curavac.com\/#website\"},\"datePublished\":\"2025-02-27T22:08:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.curavac.com\/company-2#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.curavac.com\/company-2\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.curavac.com\/company-2#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.curavac.com\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Empresa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.curavac.com\/#website\",\"url\":\"https:\/\/www.curavac.com\/\",\"name\":\"CuraVac\",\"description\":\"Targeted Active Therapy for Autoimmune Diseases\",\"publisher\":{\"@id\":\"https:\/\/www.curavac.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.curavac.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.curavac.com\/#organization\",\"name\":\"CuraVac\",\"url\":\"https:\/\/www.curavac.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.curavac.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.curavac.com\/wp-content\/uploads\/2025\/04\/cropped-cropped-Taransparant-4.png\",\"contentUrl\":\"https:\/\/www.curavac.com\/wp-content\/uploads\/2025\/04\/cropped-cropped-Taransparant-4.png\",\"width\":1215,\"height\":331,\"caption\":\"CuraVac\"},\"image\":{\"@id\":\"https:\/\/www.curavac.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Empresa - CuraVac","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curavac.com\/company-2","og_locale":"es_ES","og_type":"article","og_title":"Empresa - CuraVac","og_description":"CuraVac es una empresa biotecnol\u00f3gica en fase cl\u00ednica que desarrolla Vacunas Terap\u00e9uticas e Inmunoterapias Activas Dirigidas para enfermedades autoinmunes. Con el uso de una nueva t\u00e9cnica revolucionaria basada en p\u00e9ptidos complementarios, pretendemos inducir inmunidad a largo plazo contra enfermedades autoinmunes como la esclerosis m\u00faltiple (EM), la miastenia grave (MG), la diabetes de tipo 1, la &hellip; Empresa Leer m\u00e1s &raquo;","og_url":"https:\/\/www.curavac.com\/company-2","og_site_name":"CuraVac","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.curavac.com\/company-2","url":"https:\/\/www.curavac.com\/company-2","name":"Empresa - CuraVac","isPartOf":{"@id":"https:\/\/www.curavac.com\/#website"},"datePublished":"2025-02-27T22:08:56+00:00","breadcrumb":{"@id":"https:\/\/www.curavac.com\/company-2#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curavac.com\/company-2"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.curavac.com\/company-2#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curavac.com\/es"},{"@type":"ListItem","position":2,"name":"Empresa"}]},{"@type":"WebSite","@id":"https:\/\/www.curavac.com\/#website","url":"https:\/\/www.curavac.com\/","name":"CuraVac","description":"Targeted Active Therapy for Autoimmune Diseases","publisher":{"@id":"https:\/\/www.curavac.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curavac.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.curavac.com\/#organization","name":"CuraVac","url":"https:\/\/www.curavac.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.curavac.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.curavac.com\/wp-content\/uploads\/2025\/04\/cropped-cropped-Taransparant-4.png","contentUrl":"https:\/\/www.curavac.com\/wp-content\/uploads\/2025\/04\/cropped-cropped-Taransparant-4.png","width":1215,"height":331,"caption":"CuraVac"},"image":{"@id":"https:\/\/www.curavac.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.curavac.com\/es\/wp-json\/wp\/v2\/pages\/3421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curavac.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.curavac.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.curavac.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curavac.com\/es\/wp-json\/wp\/v2\/comments?post=3421"}],"version-history":[{"count":1,"href":"https:\/\/www.curavac.com\/es\/wp-json\/wp\/v2\/pages\/3421\/revisions"}],"predecessor-version":[{"id":3422,"href":"https:\/\/www.curavac.com\/es\/wp-json\/wp\/v2\/pages\/3421\/revisions\/3422"}],"wp:attachment":[{"href":"https:\/\/www.curavac.com\/es\/wp-json\/wp\/v2\/media?parent=3421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}